Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial

Arturo Rojas,Georgina Sposetti,Jorge Luiz Gross,Douglas Eugenio Barbieri,Ran Duan,Bruno Linetzky,Janaina Martins De Lana,Oded Stempa,Ángel Rodríguez

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial

2015

Arturo Rojas
Georgina Sposetti
Jorge Luiz Gross
Douglas Eugenio Barbieri
Ran Duan
Bruno Linetzky
Janaina Martins De Lana
Oded Stempa
Ángel Rodríguez

Background This post hoc analysis examined the efficacy and safety of twice-daily insulin lispro low mixture (LM25) and once-daily basal insulin glargine plus once-daily prandial insulin lispro (IGL) in a Latin American subpopulation with type 2 diabetes mellitus (T2DM).

Keywords:

Metformin
Insulin glargine
Pioglitazone
Insulin
Endocrinology
Internal medicine
Type 2 diabetes
Diabetes mellitus
Medicine
Insulin lispro
Type 2 Diabetes Mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations